Fast Five Quiz: Menopause and Hormone Therapy

Richard Scott Lucidi, MD, FACOG


September 01, 2022

Dysfunctional uterine bleeding is a relative contraindication for HT. While bleeding commonly occurs owing to benign conditions, all menopausal women with unexplained uterine bleeding should be evaluated for endometrial hyperplasia/carcinoma prior to starting HT.

HT is contraindicated in women who themselves have a history of stroke or blood clotting disorders; however, it is not contraindicated in women with a family history of stroke.

Other relative contraindications for HT include:

  • A history of estrogen-dependent cancers

  • Porphyria

  • Severe active liver disease

  • Endometriosis

  • Hypertriglyceridemia

  • Fibroids

HT may be used to relieve frequent episodes of vasomotor symptoms, such as hot flashes or night sweats.

Learn more about menopausal HT.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.